文献速递临床试验与 GCP真实世界研究与卫生经济

机器人臂辅助与传统全膝关节置换术比较:RACER-Knee实用随机对照试验

Robotic-arm-assisted versus conventional total knee replacement (RACER-Knee): a pragmatic, multicentre, participant-masked and assessor-masked, superiority, randomised controlled trial.
PubMed 文献 · Lancet · 2026-08-20

BACKGROUND: Robotic systems are being increasingly used to assist with total knee replacement (TKR). Whether robotic systems improve outcomes after TKR is uncertain.…

要点

  • rTKR在常规实践中成本高于cTKR,未显示额外患者获益。
  • 两组严重不良事件各16例,安全性特征相似。

核心结论

  • 在实用试验条件下,rTKR较cTKR成本更高,且12个月时未提供临床有意义的患者获益。
  • 两组安全性(即伤害)特征相似。

研究设计与样本

  • 807例患者筛查,339例随机分配:168例至rTKR组,171例至cTKR组。
  • 参与者通过远程计算机系统按1:1随机,采用最小化法按年龄、BMI、中心、外科医生和主要受累膝关节间室平衡。
  • 主要结局为随机化后12个月Forgotten Joint Score(FJS),按意向性治疗原则用线性混合效应模型分析;预设目标差异为12分。

主要发现

  • 每组各有16例参与者发生一次严重不良事件。

关键数值与推荐

  • 纳入标准:晚期膝骨关节炎行全膝关节置换者。
  • 关键排除标准:炎性关节病、既往骨折或需要复杂植入物。
  • 主要结局预设目标差异为12分(FJS)。

临床怎么用

  • 在常规实践中,rTKR不应仅基于预期临床获益而优先于cTKR使用。
  • 决策时需考虑rTKR成本更高且12个月患者报告结局与cTKR相似。

局限性

  • 长期随访仍在进行中,当前报告为12个月结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Robotic systems are being increasingly used to assist with total knee replacement (TKR). Whether robotic systems improve outcomes after TKR is uncertain. We aimed to ascertain the clinical efficacy and cost-effectiveness of the Mako robotic-arm system compared with conventional instruments for TKR. METHODS: We conducted a participant-masked and assessor-masked pragmatic, superiority, randomised controlled trial at ten hospitals in Great Britain involving 33 surgeons. Patients with advanced knee osteoarthritis underwent TKR with conventional instruments (cTKR) or with the Mako robotic-arm-assisted system (rTKR). Key exclusion criteria were inflammatory arthropathy, previous fracture, or the need for complex implants. Participants were randomly assigned (1:1) through a remote computer system using minimisation by age, BMI, centre, surgeon, and primary knee compartment involved. Participants and assessors were masked through methods including using sham incisions, additional draping, and masked operation notes. The primary outcome was the Forgotten Joint Score (FJS) at 12 months after randomisation according to the intention-to-treat principle using a linear mixed-effects model. The prespecified target difference was 12 points. The trial is registered with ISRCTN (ISRCTN27624068), and long-term follow-up is ongoing. FINDINGS: Between Dec 21, 2021, and Dec 13, 2023, 807 patients were screened and 339 were randomly assigned: 168 to rTKR and 171 to cTKR. The median age was 68·8 years (IQR 61·3-75·2), 167 (49%) were female, and 172 (51%) were male. At 12 months, the mean FJS was 49·2 (SD 28·4; n=154) in the rTKR group and 50·2 (29·9; n=158) in the cTKR group. The adjusted mean difference was -1·5 (95% CI -7·5 to 4·5; p=0·62,) favouring cTKR. 16 participants in each group had one serious adverse event. INTERPRETATION: In this pragmatic trial, rTKR as delivered in routine practice was more costly than cTKR and did not provide a clinically meaningful patient benefit at 12 months after randomisation. The two groups had similar safety (ie, harms) profiles. FUNDING: UK National Institute for Health and Care Research Health Technology Assessment Programme.

来源:Lancet,查看原文。版权归原作者所有。

引用

  1. Parsons H, Metcalfe A, Griffin J, et al. Robotic-arm-assisted versus conventional total knee replacement (RACER-Knee): a pragmatic, multicentre, participant-masked and assessor-masked, superiority, randomised controlled trial. Lancet. 2026. PMID: 42624811. doi:10.1016/S0140-6736(26)00986-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。